Inactive Instrument

News Ranbaxy Laboratories Limited

Equities

RANB

INE015A01028

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

2016	UCB : Pharma crusader takes India's drug regulators to court	RE
2015	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UCB : Pharma crusader takes India's drug regulators to court	16-03-07	RE
Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	15-06-28	RE
DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	15-04-20	RE
Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	15-03-04	PU
DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	15-01-30	RE
Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	15-01-28	PU
Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	14-12-06	PU
AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	14-12-05	RE
Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	14-12-01	PU
AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	14-11-20	RE
AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	14-11-18	RE
GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	14-10-28	RE
AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	14-07-31	RE
Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	14-07-29	PU
AbbVie : AstraZeneca results to get lift from bid foe Pfizer	14-07-25	RE
Ranbaxy Laboratories : and Cipher Announce Signing of Licensing Agreement for Isotretinoin	14-07-24	PU
Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	14-07-17	RE
Ranbaxy Laboratories : OHM Laboratories To Launch Valsartan Tablets	14-06-27	PU
Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	14-06-24	RE
Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	14-06-19	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ranbaxy Laboratories Limited

Equities

RANB

INE015A01028

Summary

Filters